Plasma Pharmacokinetics of N-Acetylgalactosamine-Conjugated Small-Interfering Ribonucleic Acids (GalNAc-Conjugated siRNAs) Sebastian StenTim CardilinPeter Gennemark Leading Article Open access 12 October 2023 Pages: 1661 - 1672
The Pharmacokinetics of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Roland HeinigThomas Eissing Review Article Open access 24 October 2023 Pages: 1673 - 1693
High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints Anouk M. E. JansenRob ter HeineRoger J. M. Brüggemann Commentary Open access 11 October 2023 Pages: 1695 - 1699
Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies Anouk M. E. JansenBeatrijs MertensRoger J. M. Brüggemann Original Research Article Open access 11 October 2023 Pages: 1701 - 1711
Pharmacokinetics and Tolerability of Zibotentan in Patients with Concurrent Moderate Renal and Moderate Hepatic Impairment Anne-Kristina MercierMikael SunnåkerJan Oscarsson Original Research Article Open access 06 October 2023 Pages: 1713 - 1724
Population Pharmacokinetics of Digoxin in Nonagenarian Patients: Optimization of the Dosing Regimen Angel Luis Salcedo-MingoarranzSusanna Edith Medellín-GaribayBenito García-Díaz Original Research Article 10 October 2023 Pages: 1725 - 1738
Safety, Pharmacokinetics, and Pharmacodynamics of SHR7280, a Non-peptide GnRH Antagonist in Premenopausal Women with Endometriosis: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study Yuan LiYing ZhengHongyan Guo Original Research Article 14 October 2023 Pages: 1739 - 1748
Prognostic Value of Nivolumab Clearance in Non-Small Cell Lung Cancer Patients for Survival Early in Treatment Leila S. OttenBerber PietMichel M. van den Heuvel Original Research Article Open access 19 October 2023 Pages: 1749 - 1754
A Phase I, Open-Label, Fixed Sequence Study to Investigate the Effect of Cytochrome P450 2D6 Inhibition on the Pharmacokinetics of Ulotaront in Healthy Subjects Hironobu TsukadaYu-Luan ChenGerald R. Galluppi Original Research Article Open access 26 October 2023 Pages: 1755 - 1763
Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development Jessica WojciechowskiVivek S PurohitTimothy Nicholas Original Research Article Open access 02 November 2023 Pages: 1765 - 1779